32nd Annual EAU Congress, March 24-28, 2017, London, UK
Pantarhei Oncology will be visiting the 32nd Annual EAU Congress in London. A poster presentation by Ellen Dutman, CRA at Pantarhei, on Saturday March 25th will show the results of a clinical study with the estrogen E4 in healthy men. The objective of the study was to investigate the efficacy and safety of estetrol for its potential use in the treatment of prostate cancer with special emphasis on the effect of estetrol on testosterone levels. The results suggest that E4 may be suitable for the treatment of advanced prostate cancer.